Skip to main content
Top
Published in: Surgical Endoscopy 5/2024

11-03-2024 | Gastroesophageal Reflux Disease

Prolonged acid reflux monitoring using acid exposure time and DeMeester score: two days are not enough

Authors: Michelle E. Lee, Gaurav Ghosh, Katharine Rooney, Amir Soumekh, Felice Schnoll-Sussman, Philip Katz

Published in: Surgical Endoscopy | Issue 5/2024

Login to get access

Abstract

Background

Wireless pH monitoring allows for a definitive GERD diagnosis, which is essential for optimal medical or surgical management of the patient. However, there is no guideline recommendation on whether prolonged pH testing (72 or 96 h) provides additional benefit when compared to the standard 48-h testing. We aimed to assess whether prolonged pH monitoring diagnoses more patients with GERD, as well as compare the DeMeester score to acid exposure time as diagnostic criteria for GERD.

Methods

This was a retrospective analysis of consecutive adult patients who underwent wireless esophageal pH monitoring between August 2018 and July 2021. The primary outcome was the additional diagnoses of GERD (predominant acid exposure pattern) in patients who underwent 48-h versus 96-h pH monitoring. Secondary outcomes included comparison of the DeMeester score to acid exposure time and internal agreement between the first and second 48-h blocks of a prolonged 96-h pH study.

Results

When comparing 48-h versus 96-h pH testing, the prolonged monitoring group was more likely to have a predominant reflux pattern and thus be diagnosed with definitive GERD by elevated DeMeester score (58.8% vs. 40.8%, p = 0.003) or acid exposure time > 6% (44.7% vs. 32.4%, p = 0.039). For patients who underwent prolonged testing, the results of monitoring beyond 48 h led to a clinically meaningful change in study interpretation in 24.8% of patients. The study data from Days 3 to 4 yielded only a 56.6% agreement with the first 2 days.

Conclusions

In patients undergoing extended pH monitoring, almost half were found to have an abnormal pH study after a normal study on Day 1. An additional 25% of patients had a change in study interpretation by extending the study beyond 48 h. Our findings suggest only 48 h of pH monitoring will miss a diagnosis of GERD in a clinically important number of patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gyawali CP, Kahrilas PJ, Savarino E, Zerbib F, Mion F, Smout AJPM, Vaezi M, Sifrim D, Fox MR, Vela MF, Tutuian R, Tack J, Bredenoord AJ, Pandolfino J, Roman S (2018) Modern diagnosis of GERD: the Lyon consensus. Gut 67:1351CrossRefPubMed Gyawali CP, Kahrilas PJ, Savarino E, Zerbib F, Mion F, Smout AJPM, Vaezi M, Sifrim D, Fox MR, Vela MF, Tutuian R, Tack J, Bredenoord AJ, Pandolfino J, Roman S (2018) Modern diagnosis of GERD: the Lyon consensus. Gut 67:1351CrossRefPubMed
2.
go back to reference Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ (2022) ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 117:27–56CrossRefPubMedPubMedCentral Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ (2022) ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 117:27–56CrossRefPubMedPubMedCentral
3.
go back to reference Yadlapati R, Gyawali CP, Masihi M, Carlson DA, Kahrilas PJ, Nix BD, Jain A, Triggs JR, Vaezi MF, Kia L, Kaizer A, Pandolfino JE (2022) Optimal wireless reflux monitoring metrics to predict discontinuation of proton pump inhibitor therapy. Off J Am College Gastroenterol 117(10):1573CrossRef Yadlapati R, Gyawali CP, Masihi M, Carlson DA, Kahrilas PJ, Nix BD, Jain A, Triggs JR, Vaezi MF, Kia L, Kaizer A, Pandolfino JE (2022) Optimal wireless reflux monitoring metrics to predict discontinuation of proton pump inhibitor therapy. Off J Am College Gastroenterol 117(10):1573CrossRef
4.
go back to reference Yadlapati R, Gyawali CP, Pandolfino JE (2022) AGA clinical practice update on the personalized approach to the evaluation and management of GERD: expert review. Clin Gastroenterol Hepatol 20:984-994.e981CrossRefPubMedPubMedCentral Yadlapati R, Gyawali CP, Pandolfino JE (2022) AGA clinical practice update on the personalized approach to the evaluation and management of GERD: expert review. Clin Gastroenterol Hepatol 20:984-994.e981CrossRefPubMedPubMedCentral
5.
go back to reference Dimou FM, Lidor A, Velanovich V (2023) Commentary on the multi-society consensus conference and guideline on the treatment of gastroesophageal reflux disease (GERD). J Gastrointest Surg 27:650CrossRefPubMed Dimou FM, Lidor A, Velanovich V (2023) Commentary on the multi-society consensus conference and guideline on the treatment of gastroesophageal reflux disease (GERD). J Gastrointest Surg 27:650CrossRefPubMed
6.
go back to reference Moore M, Afaneh C, Benhuri D, Antonacci C, Abelson J, Zarnegar R (2016) Gastroesophageal reflux disease: a review of surgical decision making. World J Gastrointest Surg 8:77–83CrossRefPubMedPubMedCentral Moore M, Afaneh C, Benhuri D, Antonacci C, Abelson J, Zarnegar R (2016) Gastroesophageal reflux disease: a review of surgical decision making. World J Gastrointest Surg 8:77–83CrossRefPubMedPubMedCentral
7.
go back to reference Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, Fanelli RD, The SGC (2010) Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc 24:2647–2669CrossRefPubMed Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, Fanelli RD, The SGC (2010) Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc 24:2647–2669CrossRefPubMed
8.
go back to reference Hasak S, Yadlapati R, Altayar O, Sweis R, Tucker E, Knowles K, Fox M, Pandolfino J, Gyawali CP (2020) Prolonged wireless pH monitoring in patients with persistent reflux symptoms despite proton pump inhibitor therapy. Clin Gastroenterol Hepatol 18:2912–2919CrossRefPubMedPubMedCentral Hasak S, Yadlapati R, Altayar O, Sweis R, Tucker E, Knowles K, Fox M, Pandolfino J, Gyawali CP (2020) Prolonged wireless pH monitoring in patients with persistent reflux symptoms despite proton pump inhibitor therapy. Clin Gastroenterol Hepatol 18:2912–2919CrossRefPubMedPubMedCentral
9.
go back to reference Sweis R, Fox M, Anggiansah R, Anggiansah A, Basavaraju K, Canavan R, Wong T (2009) Patient acceptance and clinical impact of Bravo monitoring in patients with previous failed catheter-based studies. Aliment Pharmacol Ther 29:669–676CrossRefPubMed Sweis R, Fox M, Anggiansah R, Anggiansah A, Basavaraju K, Canavan R, Wong T (2009) Patient acceptance and clinical impact of Bravo monitoring in patients with previous failed catheter-based studies. Aliment Pharmacol Ther 29:669–676CrossRefPubMed
10.
go back to reference Sweis R, Fox M, Anggiansah A, Wong T (2011) Prolonged, wireless pH-studies have a high diagnostic yield in patients with reflux symptoms and negative 24-h catheter-based pH-studies. Neurogastroenterol Motil 23:419–426CrossRefPubMed Sweis R, Fox M, Anggiansah A, Wong T (2011) Prolonged, wireless pH-studies have a high diagnostic yield in patients with reflux symptoms and negative 24-h catheter-based pH-studies. Neurogastroenterol Motil 23:419–426CrossRefPubMed
11.
go back to reference Slater BJ, Collings A, Dirks R, Gould JC, Qureshi AP, Juza R, Rodríguez-Luna MR, Wunker C, Kohn GP, Kothari S, Carslon E, Worrell S, Abou-Setta AM, Ansari MT, Athanasiadis DI, Daly S, Dimou F, Haskins IN, Hong J, Krishnan K, Lidor A, Litle V, Low D, Petrick A, Soriano IS, Thosani N, Tyberg A, Velanovich V, Vilallonga R, Marks JM (2023) Multi-society consensus conference and guideline on the treatment of gastroesophageal reflux disease (GERD). Surg Endosc 37:781–806CrossRefPubMed Slater BJ, Collings A, Dirks R, Gould JC, Qureshi AP, Juza R, Rodríguez-Luna MR, Wunker C, Kohn GP, Kothari S, Carslon E, Worrell S, Abou-Setta AM, Ansari MT, Athanasiadis DI, Daly S, Dimou F, Haskins IN, Hong J, Krishnan K, Lidor A, Litle V, Low D, Petrick A, Soriano IS, Thosani N, Tyberg A, Velanovich V, Vilallonga R, Marks JM (2023) Multi-society consensus conference and guideline on the treatment of gastroesophageal reflux disease (GERD). Surg Endosc 37:781–806CrossRefPubMed
12.
go back to reference Yadlapati R, Gawron AJ, Gyawali CP, Chen J, Clarke J, Fass R, Jain A, Lynch K, Khan A, Katz PO, Katzka DA, Richter J, Schnoll-Sussman F, Spechler SJ, Vaezi MF, Vela M, Pandolfino JE (2022) Clinical role of ambulatory reflux monitoring in PPI non-responders: recommendation statements. Aliment Pharmacol Ther 56:1274–1283CrossRefPubMedPubMedCentral Yadlapati R, Gawron AJ, Gyawali CP, Chen J, Clarke J, Fass R, Jain A, Lynch K, Khan A, Katz PO, Katzka DA, Richter J, Schnoll-Sussman F, Spechler SJ, Vaezi MF, Vela M, Pandolfino JE (2022) Clinical role of ambulatory reflux monitoring in PPI non-responders: recommendation statements. Aliment Pharmacol Ther 56:1274–1283CrossRefPubMedPubMedCentral
13.
go back to reference Pandolfino JE, Richter JE, Ours T, Guardino JM, Chapman J, Kahrilas PJ (2003) Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 98:740–749CrossRefPubMed Pandolfino JE, Richter JE, Ours T, Guardino JM, Chapman J, Kahrilas PJ (2003) Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 98:740–749CrossRefPubMed
14.
go back to reference Scarpulla G, Camilleri S, Galante P, Manganaro M, Fox M (2007) The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies. Am J Gastroenterol 102:2642–2647CrossRefPubMed Scarpulla G, Camilleri S, Galante P, Manganaro M, Fox M (2007) The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies. Am J Gastroenterol 102:2642–2647CrossRefPubMed
15.
go back to reference Hirano I, Zhang Q, Pandolfino JE, Kahrilas PJ (2005) Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy. Clin Gastroenterol Hepatol 3:1083–1088CrossRefPubMed Hirano I, Zhang Q, Pandolfino JE, Kahrilas PJ (2005) Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy. Clin Gastroenterol Hepatol 3:1083–1088CrossRefPubMed
16.
go back to reference Ayazi S, Hagen JA, Zehetner J, Banki F, Augustin F, Ayazi A, DeMeester SR, Oh DS, Sohn HJ, Lipham JC, DeMeester TR (2011) Day-to-day discrepancy in Bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease. Surg Endosc 25:2219–2223CrossRefPubMedPubMedCentral Ayazi S, Hagen JA, Zehetner J, Banki F, Augustin F, Ayazi A, DeMeester SR, Oh DS, Sohn HJ, Lipham JC, DeMeester TR (2011) Day-to-day discrepancy in Bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease. Surg Endosc 25:2219–2223CrossRefPubMedPubMedCentral
17.
go back to reference Yadlapati R, Masihi M, Gyawali CP, Carlson DA, Kahrilas PJ, Nix BD, Jain A, Triggs JR, Vaezi MF, Kia L, Kaizer A, Pandolfino JE (2021) Ambulatory reflux monitoring guides proton pump inhibitor discontinuation in patients with gastroesophageal reflux symptoms: a clinical trial. Gastroenterology 160:174-182.e171CrossRefPubMed Yadlapati R, Masihi M, Gyawali CP, Carlson DA, Kahrilas PJ, Nix BD, Jain A, Triggs JR, Vaezi MF, Kia L, Kaizer A, Pandolfino JE (2021) Ambulatory reflux monitoring guides proton pump inhibitor discontinuation in patients with gastroesophageal reflux symptoms: a clinical trial. Gastroenterology 160:174-182.e171CrossRefPubMed
18.
go back to reference Johnson LF, Demeester TR (1974) Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 62:325–332PubMed Johnson LF, Demeester TR (1974) Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 62:325–332PubMed
Metadata
Title
Prolonged acid reflux monitoring using acid exposure time and DeMeester score: two days are not enough
Authors
Michelle E. Lee
Gaurav Ghosh
Katharine Rooney
Amir Soumekh
Felice Schnoll-Sussman
Philip Katz
Publication date
11-03-2024
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 5/2024
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-024-10733-x

Other articles of this Issue 5/2024

Surgical Endoscopy 5/2024 Go to the issue